These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22137330)

  • 1. Genome-wide study links MTMR7 gene to variant Creutzfeldt-Jakob risk.
    Sanchez-Juan P; Bishop MT; Aulchenko YS; Brandel JP; Rivadeneira F; Struchalin M; Lambert JC; Amouyel P; Combarros O; Sainz J; Carracedo A; Uitterlinden AG; Hofman A; Zerr I; Kretzschmar HA; Laplanche JL; Knight RS; Will RG; van Duijn CM
    Neurobiol Aging; 2012 Jul; 33(7):1487.e21-8. PubMed ID: 22137330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study.
    Mead S; Poulter M; Uphill J; Beck J; Whitfield J; Webb TE; Campbell T; Adamson G; Deriziotis P; Tabrizi SJ; Hummerich H; Verzilli C; Alpers MP; Whittaker JC; Collinge J
    Lancet Neurol; 2009 Jan; 8(1):57-66. PubMed ID: 19081515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in the prion protein gene and in the doppel gene increase susceptibility for Creutzfeldt-Jakob disease.
    Croes EA; Alizadeh BZ; Bertoli-Avella AM; Rademaker T; Vergeer-Drop J; Dermaut B; Houwing-Duistermaat JJ; Wientjens DP; Hofman A; Van Broeckhoven C; van Duijn CM
    Eur J Hum Genet; 2004 May; 12(5):389-94. PubMed ID: 14970845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study.
    Jones E; Hummerich H; Viré E; Uphill J; Dimitriadis A; Speedy H; Campbell T; Norsworthy P; Quinn L; Whitfield J; Linehan J; Jaunmuktane Z; Brandner S; Jat P; Nihat A; How Mok T; Ahmed P; Collins S; Stehmann C; Sarros S; Kovacs GG; Geschwind MD; Golubjatnikov A; Frontzek K; Budka H; Aguzzi A; Karamujić-Čomić H; van der Lee SJ; Ibrahim-Verbaas CA; van Duijn CM; Sikorska B; Golanska E; Liberski PP; Calero M; Calero O; Sanchez-Juan P; Salas A; Martinón-Torres F; Bouaziz-Amar E; Haïk S; Laplanche JL; Brandel JP; Amouyel P; Lambert JC; Parchi P; Bartoletti-Stella A; Capellari S; Poleggi A; Ladogana A; Pocchiari M; Aneli S; Matullo G; Knight R; Zafar S; Zerr I; Booth S; Coulthart MB; Jansen GH; Glisic K; Blevins J; Gambetti P; Safar J; Appleby B; Collinge J; Mead S
    Lancet Neurol; 2020 Oct; 19(10):840-848. PubMed ID: 32949544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No evidence for association between tau gene haplotypic variants and susceptibility to Creutzfeldt-Jakob disease.
    Sánchez-Juan P; Bishop MT; Green A; Giannattasio C; Arias-Vasquez A; Poleggi A; Knight RS; van Duijn CM
    BMC Med Genet; 2007 Dec; 8():77. PubMed ID: 18072964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A genome wide association study links glutamate receptor pathway to sporadic Creutzfeldt-Jakob disease risk.
    Sanchez-Juan P; Bishop MT; Kovacs GG; Calero M; Aulchenko YS; Ladogana A; Boyd A; Lewis V; Ponto C; Calero O; Poleggi A; Carracedo Á; van der Lee SJ; Ströbel T; Rivadeneira F; Hofman A; Haïk S; Combarros O; Berciano J; Uitterlinden AG; Collins SJ; Budka H; Brandel JP; Laplanche JL; Pocchiari M; Zerr I; Knight RS; Will RG; van Duijn CM
    PLoS One; 2014; 10(4):e0123654. PubMed ID: 25918841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variants of PLCXD3 are not associated with variant or sporadic Creutzfeldt-Jakob disease in a large international study.
    Balendra R; Uphill J; Collinson C; Druyeh R; Adamson G; Hummerich H; Zerr I; Gambetti P; Collinge J; Mead S
    BMC Med Genet; 2016 Apr; 17():28. PubMed ID: 27055460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRNP contains both intronic and upstream regulatory regions that may influence susceptibility to Creutzfeldt-Jakob Disease.
    McCormack JE; Baybutt HN; Everington D; Will RG; Ironside JW; Manson JC
    Gene; 2002 Apr; 288(1-2):139-46. PubMed ID: 12034503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creutzfeldt-Jakob disease surveillance in Argentina, 1997-2008.
    Begué C; Martinetto H; Schultz M; Rojas E; Romero C; D'Giano C; Sevlever G; Somoza M; Taratuto AL
    Neuroepidemiology; 2011; 37(3-4):193-202. PubMed ID: 22067221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dealing with the uncertain risk of variant Creutzfeldt-Jakob disease transmission by coagulation replacement products.
    Millar CM; Makris M
    Br J Haematol; 2012 Aug; 158(4):442-52. PubMed ID: 22775486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Creutzfeldt-Jakob disease--the past or the future].
    Kulczycki J
    Przegl Epidemiol; 2006; 60 Suppl 1():63-7. PubMed ID: 16909780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E and other cerebrospinal fluid proteins differentiate ante mortem variant Creutzfeldt-Jakob disease from ante mortem sporadic Creutzfeldt-Jakob disease.
    Choe LH; Green A; Knight RS; Thompson EJ; Lee KH
    Electrophoresis; 2002 Jul; 23(14):2242-6. PubMed ID: 12210228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MHC typing in variant Creutzfeldt-Jakob disease.
    Pepys MB; Bybee A; Booth DR; Bishop MT; Will RG; Little AM; Prokupek B; Madrigal JA
    Lancet; 2003 Feb; 361(9356):487-9. PubMed ID: 12583949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada.
    Ladogana A; Puopolo M; Croes EA; Budka H; Jarius C; Collins S; Klug GM; Sutcliffe T; Giulivi A; Alperovitch A; Delasnerie-Laupretre N; Brandel JP; Poser S; Kretzschmar H; Rietveld I; Mitrova E; Cuesta Jde P; Martinez-Martin P; Glatzel M; Aguzzi A; Knight R; Ward H; Pocchiari M; van Duijn CM; Will RG; Zerr I
    Neurology; 2005 May; 64(9):1586-91. PubMed ID: 15883321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Australian sporadic CJD analysis supports endogenous determinants of molecular-clinical profiles.
    Lewis V; Hill AF; Klug GM; Boyd A; Masters CL; Collins SJ
    Neurology; 2005 Jul; 65(1):113-8. PubMed ID: 16009895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Young-onset CJD: age and disease phenotype in variant and sporadic forms.
    Corato M; Cereda C; Cova E; Ferrarese C; Ceroni M
    Funct Neurol; 2006; 21(4):211-5. PubMed ID: 17367581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic risk factors associated with Creutzfeld-Jakob disease in Slovenians and a rapid typing for PRNP codon 129 single nucleotide polymorphism.
    Galvani V; Rupreht RR; Serbec VC; Vidan-Jeras B
    Transfus Med; 2005 Jun; 15(3):197-207. PubMed ID: 15943704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease.
    Van Everbroeck B; Boons J; Cras P
    Clin Neurol Neurosurg; 2005 Aug; 107(5):355-60. PubMed ID: 16023527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Psychiatric manifestations of a new variant of Creutzfeldt-Jakob disease. Apropos of a case].
    Dervaux A; Vicart S; Lopes F; Le Borgne MH
    Encephale; 2001; 27(2):194-7. PubMed ID: 11407273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Description and analysis of 12 years of surveillance for Creutzfeldt-Jakob disease in Denmark, 1997 to 2008.
    Gubbels S; Bacci S; Laursen H; Hogenhaven H; Cowan S; Molbak K; Christiansen M
    Euro Surveill; 2012 Apr; 17(15):. PubMed ID: 22516048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.